Saizen Liquid 20 mg (8 mg/ml) Solution injectable Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

saizen liquid 20 mg (8 mg/ml) solution injectable

merck (schweiz) ag - somatropinum adnr - solution injectable - somatropinum adnr 20.0 mg, saccharum, poloxamerum 188, phenolum, acidum citricum, natrii hydroxidum corresp. natrium max. 0.47 µg, aqua ad iniectabilia q.s. ad solutionem pro 2.5 ml. - hypophysärer nanisme; petite stature cas de syndrome de turner; insuffisance rénale chronique chez l'enfant; sga; déficit en hormone de croissance chez l'adulte, la suite de l'hypothalamus ou hypophysärer maladie - biotechnologika

Insulin Lilly Huminsulin Basal KwikPen stylo prérempli suspension injectable Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

insulin lilly huminsulin basal kwikpen stylo prérempli suspension injectable

eli lilly (suisse) sa - insulinum humanum adnr isophanum - suspension injectable - insulinum humanum adnr isophanum 100 u.i., metacresolum, glycerolum, phenolum, protamini sulfas, dinatrii phosphas heptahydricus, zinci oxidum, acidum hydrochloridum dilutum q.s. ad ph, natrii hydroxidum q.s. ad ph, aqua ad iniectabile q.s. ad suspensionem pro 1 ml corresp. natrium 0.6 mg. - diabète sucré - biotechnologika

Insulin NovoNordisk NovoRapid FlexTouch Solution injectable Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

insulin novonordisk novorapid flextouch solution injectable

novo nordisk pharma ag - insulinum aspartum - solution injectable - insulinum aspartum 100 u.i., glycerolum, zincum ut zinci chloridum, natrii phosphates, natrii chloridum, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - le diabète sucré - biotechnologika

Tresiba Penfill Solution injectable Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

tresiba penfill solution injectable

novo nordisk pharma ag - insulinum degludecum - solution injectable - insulinum degludecum 600 nmol corresp. insulinum degludecum 100 u., glycerolum, zincum ut zinci acetas dihydricus, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - le diabète sucré - biotechnologika

Tresiba FlexTouch 100 E/ml Solution injectable Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

tresiba flextouch 100 e/ml solution injectable

novo nordisk pharma ag - insulinum degludecum - solution injectable - insulinum degludecum 600 nmol corresp. insulinum degludecum 100 u., glycerolum, zincum ut zinci acetas dihydricus, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - le diabète sucré - biotechnologika

Tresiba FlexTouch 200 E/ml Solution injectable Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

tresiba flextouch 200 e/ml solution injectable

novo nordisk pharma ag - insulinum degludecum - solution injectable - insulinum degludecum 1200 nmol corresp. insulinum degludecum 200 u., glycerolum, zincum ut zinci acetas dihydricus, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - le diabète sucré - biotechnologika

Ryzodeg Penfill Solution injectable Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

ryzodeg penfill solution injectable

novo nordisk pharma ag - insulinum degludecum, insulinum aspartum - solution injectable - insulinum degludecum 420 nmol corresp. insulinum degludecum 70 u., insulinum aspartum 180 nmol corresp. insulinum aspartum 30 u., glycerolum, natrii chloridum, zincum ut zinci acetas dihydricus, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - le diabète sucré - biotechnologika

Ryzodeg FlexTouch Solution injectable Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

ryzodeg flextouch solution injectable

novo nordisk pharma ag - insulinum degludecum, insulinum aspartum - solution injectable - insulinum degludecum 420 nmol corresp. insulinum degludecum 70 u., insulinum aspartum 180 nmol corresp. insulinum aspartum 30 u., glycerolum, natrii chloridum, zincum ut zinci acetas dihydricus, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - le diabète sucré - biotechnologika

Xultophy Insulin Degludec 100 E/ml und Liraglutide 3.6 mg/ml Solution injectable Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

xultophy insulin degludec 100 e/ml und liraglutide 3.6 mg/ml solution injectable

novo nordisk pharma ag - insulinum degludecum, liraglutidum - solution injectable - insulinum degludecum 600 nmol corresp. insulinum degludecum 100 u., liraglutidum 3.6 mg, phenolum, glycerolum, zincum ut zinci acetas dihydricus, acidum hydrochloridum, natrii hydroxidum corresp. natrium max. 0.0416 mmol, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - diabète de l'adulte - biotechnologika

Abasaglar cartouche 100 U/ml solution injectable Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

abasaglar cartouche 100 u/ml solution injectable

eli lilly (suisse) sa - insulinum glarginum - solution injectable - insulinum glarginum 3.64 mg corresp. insulinum glarginum 100 u., glycerolum, metacresolum, zincum ut zinci oxidum, acidum hydrochloridum dilutum, natrii hydroxidum corresp. natrium 0.04 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - diabète sucré - biotechnologika